Search

Your search keyword '"Leukemia therapy"' showing total 62 results

Search Constraints

Start Over You searched for: Descriptor "Leukemia therapy" Remove constraint Descriptor: "Leukemia therapy" Region japan Remove constraint Region: japan
62 results on '"Leukemia therapy"'

Search Results

2. Pharmacokinetics of 8 mg/kg anti-human T-lymphocyte rabbit immunoglobulin conditioning for hematopoietic stem cell transplantation in Japanese patients.

3. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.

4. [Hematopoietic cell transplantation in Japan: nationwide survey 2013].

7. Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.

8. Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.

9. Intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning treatment: a phase I study.

10. Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry.

11. [Recent progress in prevention and treatment of infections in leukemia patients in Japan].

13. Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.

14. [Current status and issues in hematopoietic stem cell transplantation].

15. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan.

16. Increased intensity of acute graft-versus-host disease after reduced-intensity bone marrow transplantation compared to conventional transplantation from an HLA-matched sibling in children.

17. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms.

18. [Epidemiology of visceral mycoses in patients with leukemia and MDS - Analysis of the data in annual of pathological autopsy cases in Japan in 1989, 1993, 1997 and 2001].

19. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.

20. Retrospective study on the impact of hepatitis B and hepatitis C virus infection on hematopoietic stem cell transplantation in Japan.

22. [Japan Adult Leukemia Study Group (JALSG)--twelve years of activities and future direction].

23. Mental disturbances during isolation in bone marrow transplant patients with leukemia.

24. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.

25. TT virus in bone marrow transplant recipients.

26. Trends in childhood cancer mortality as indicators of the quality of medical care in the developed world.

27. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children.

28. Unrelated umbilical cord-blood stem cell transplantation: a report from Kanagawa Cord Blood Bank, Japan.

29. Allogeneic peripheral blood stem cell transplantation for standard-risk leukemia. A multicenter pilot study: Japanese experience. Japan Blood Cell Transplantation Study Group.

30. [Current status of allogeneic-peripheral blood stem cell transplantation and the possibility for unrelated donor-peripheral blood stem cell transplantation].

32. [Therapeutic effect of donor leukocyte transfusion in relapsing marrow transplants in Japan].

33. Unrelated bone marrow transplantation from the National Marrow Donor Program.

34. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes.

35. [Bone marrow allograft using unrelated donor tissues].

36. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.

37. Effects of rhG-CSF (filgrastim) on the recovery of hematopoiesis after high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children: a report from the Children's Cancer and Leukemia Study Group of Japan.

38. Problems of bone marrow transplantation in Japan.

39. Unrelated bone marrow donor registry in Japan: the Central Coordination Committee of the Japan Marrow Donor Foundation. Japan Donor Marrow Program.

41. [Clinical Oncology Groups in Japan: experience of the Japan Adult Leukemia Study Group (JALSG)].

42. Peripheral blood stem cell autografts for the treatment of childhood cancer: a review of the Japanese experience. Japanese Cooperative Study Group of PBSCT (JCSG/PBSCT).

43. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.

44. Current progress in the treatment of adult acute leukemia in Japan.

45. Difference in onset between cytomegalovirus and idiopathic interstitial pneumonitis following allogeneic bone marrow transplantation for leukemia.

46. [Treatment and future problems of acute leukemia].

47. Statistical analysis of favorable prognostic factors in allogeneic bone marrow transplantation for acute leukemia in Japan.

48. [Aging and diseases: leukemia].

49. Present status of bone marrow transplantation in Japan.

50. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.

Catalog

Books, media, physical & digital resources